Effect of dietary advice and n-3 [omega-3 fatty acid] supplementation in newly diagnosed MS patients
Nordvik, I., Myhr, K.M., Nyland, H., Bjerve, K.S.
Department of Neurology, Haukeland University Hospital, Bergen, Norway
OBJECTIVE: To investigate whether supplementation with fish oil given together with dietary advice and vitamin supplementation influenced the clinical outcome in newly diagnosed multiple sclerosis (MS) patients.
MATERIAL AND METHODS: Sixteen consecutive, newly diagnosed patients with multiple sclerosis were recruited to an open intervention study. They were given dietary advice and supplemented with 0.9 g/day of long-chain marine [omega-3] fatty acids and vitamins. The patients were followed for two years with respect to dietary habits, blood parameters and neurological assessment including exacerbation rate.
RESULTS: There was a significant reduction in the mean annual exacerbation rate and the mean Expanded Disability Status Scale (EDSS) as compared to pre-study values. The plasma total phospholipid n-3 [omega-3] fatty acids increased and n-6 [omega-6] fatty acids decreased significantly.
CONCLUSIONS: The results suggest that fish oil supplementation given together with vitamins and dietary advice can improve clinical outcome in patients with newly diagnosed MS.
Detailed information about this study is available in PDF format at